Form 8-K - Current report:
SEC Accession No. 0001437749-20-010072
Filing Date
2020-05-08
Accepted
2020-05-08 16:22:24
Documents
2
Period of Report
2020-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200508_8k.htm 8-K 24340
2 EXHIBIT 99.1 ex_185527.htm EX-99.1 14694
  Complete submission text file 0001437749-20-010072.txt   40205
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 20860910
SIC: 2834 Pharmaceutical Preparations